These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37527173)

  • 21. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.
    Eke AC; Saccone G; Berghella V
    BJOG; 2016 Nov; 123(12):1900-1907. PubMed ID: 27239775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Selective Serotonin Reuptake Inhibitors in Prognosis Dental Implants: A Retrospective Study.
    Chandra P; Roy S; Kumari A; Agarwal R; Singh A; Sharan S
    J Pharm Bioallied Sci; 2021 Jun; 13(Suppl 1):S92-S96. PubMed ID: 34447051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective serotonin re-uptake inhibitors for premature ejaculation in adult men.
    Sathianathen NJ; Hwang EC; Mian R; Bodie JA; Soubra A; Lyon JA; Sultan S; Dahm P
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012799. PubMed ID: 33745183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective serotonin reuptake inhibitors and preeclampsia: A quality assessment and meta-analysis.
    Gumusoglu SB; Schickling BM; Vignato JA; Santillan DA; Santillan MK
    Pregnancy Hypertens; 2022 Dec; 30():36-43. PubMed ID: 35963154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective Serotonin Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn: An Update Meta-Analysis.
    Ng QX; Venkatanarayanan N; Ho CYX; Sim WS; Lim DY; Yeo WS
    J Womens Health (Larchmt); 2019 Mar; 28(3):331-338. PubMed ID: 30407100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
    Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I
    Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Association Between Antenatal Exposure to Selective Serotonin Reuptake Inhibitors and Autism: A Systematic Review and Meta-Analysis.
    Brown HK; Hussain-Shamsy N; Lunsky Y; Dennis CE; Vigod SN
    J Clin Psychiatry; 2017 Jan; 78(1):e48-e58. PubMed ID: 28129495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. THE IMPACT OF SYSTEMIC DRUGS ON DENTAL IMPLANT OSSEOINTEGRATION: A REVIEW.
    Fazliu V; Gashi-Rizaj A; Krasniqi Y; Bimbashi V
    Georgian Med News; 2024 Apr; (349):31-35. PubMed ID: 38963197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors Are Not Associated With Bleeding or Transfusion in Cardiac Surgical Patients.
    Smith MM; Smith BB; Lahr BD; Nuttall GA; Mauermann WJ; Weister TJ; Dearani JA; Barbara DW
    Anesth Analg; 2018 Jun; 126(6):1859-1866. PubMed ID: 29210786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sandblasting reduces dental implant failure rate but not marginal bone level loss: A systematic review and meta-analysis.
    Czumbel LM; Kerémi B; Gede N; Mikó A; Tóth B; Csupor D; Szabó A; Farkasdi S; Gerber G; Balaskó M; Pétervári E; Sepp R; Hegyi P; Varga G
    PLoS One; 2019; 14(5):e0216428. PubMed ID: 31050690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis.
    Zhou C; Fang L; Chen Y; Zhong J; Wang H; Xie P
    Osteoporos Int; 2018 Jun; 29(6):1243-1251. PubMed ID: 29435621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medication-related dental implant failure: Systematic review and meta-analysis.
    Chappuis V; Avila-Ortiz G; Araújo MG; Monje A
    Clin Oral Implants Res; 2018 Oct; 29 Suppl 16():55-68. PubMed ID: 30328197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implant survival in patients with neuropsychiatric, neurocognitive, and neurodegenerative disorders: A meta-analysis.
    Bera RN; Tripathi R; Bhattacharjee B; Singh AK; Kanojia S; Kumar V
    Natl J Maxillofac Surg; 2021; 12(2):162-170. PubMed ID: 34483572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of selective serotonin reuptake inhibitors and bone mass in adolescents: An NHANES study.
    Feuer AJ; Demmer RT; Thai A; Vogiatzi MG
    Bone; 2015 Sep; 78():28-33. PubMed ID: 25940460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrovascular, Cardiovascular, and Mortality Events in New Users of Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors: A Propensity Score-Matched Population-Based Study.
    Leong C; Alessi-Severini S; Enns MW; Nie Y; Sareen J; Bolton J; Prior HJ; Chateau D
    J Clin Psychopharmacol; 2017 Jun; 37(3):332-340. PubMed ID: 28383363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of bias assessment of systematic reviews regarding dental implant placement in smokers: An umbrella systematic review.
    de Oliveira-Neto OB; Barbosa FT; de Sousa-Rodrigues CF; de Lima FJC
    J Prosthet Dent; 2018 Aug; 120(2):198-203. PubMed ID: 29724548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exposure to selective serotonin reuptake inhibitors during pregnancy and risk of autism spectrum disorder in children: a systematic review and meta-analysis of observational studies.
    Man KK; Tong HH; Wong LY; Chan EW; Simonoff E; Wong IC
    Neurosci Biobehav Rev; 2015 Feb; 49():82-9. PubMed ID: 25498856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is osteoporosis a risk factor for implant survival or failure?
    Grisa A; Veitz-Keenan A
    Evid Based Dent; 2018 Jun; 19(2):51-52. PubMed ID: 29930358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective serotonin reuptake inhibitors and brain hemorrhage: a meta-analysis.
    Hackam DG; Mrkobrada M
    Neurology; 2012 Oct; 79(18):1862-5. PubMed ID: 23077009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis.
    Issari Y; Jakubovski E; Bartley CA; Pittenger C; Bloch MH
    J Clin Psychiatry; 2016 May; 77(5):e605-11. PubMed ID: 27249090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.